Phase 1 driving simulation finds bedtime GlyphAllo for major depressive disorder shows no next-morning driving impairment, while advancing allopregnanolone-based oral treatment development.
|Slideshows|September 24, 2018
Risk of Psychosis in Major Depression
Author(s)Brian Miller, MD, PhD, MPH
New findings raise the question of the optimal treatment for prevention of future psychotic depressive episodes.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
2
Searching for a New TMS Target in Schizophrenia, With Andrew Pines, MD
3
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
4
Exploring a Misuse of Neuroscience: How Biology Has Been Used to Remove Responsibility in Youth
5